Media Coverage Uncategorized Joni Henderson 6/13/21 Uncategorized Joni Henderson 6/13/21 Evaluate Vantage: Aduhelm approval amplifies amyloid assays Read More Uncategorized Joni Henderson 6/11/21 Uncategorized Joni Henderson 6/11/21 360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space Read More Uncategorized Joni Henderson 6/9/21 Uncategorized Joni Henderson 6/9/21 BioWorld™ MedTech - approval of aducanumab paves way for Alzheimer’s blood tests Read More
Uncategorized Joni Henderson 6/13/21 Uncategorized Joni Henderson 6/13/21 Evaluate Vantage: Aduhelm approval amplifies amyloid assays Read More
Uncategorized Joni Henderson 6/11/21 Uncategorized Joni Henderson 6/11/21 360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space Read More
Uncategorized Joni Henderson 6/9/21 Uncategorized Joni Henderson 6/9/21 BioWorld™ MedTech - approval of aducanumab paves way for Alzheimer’s blood tests Read More
